Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2015

Segment Reporting

Schedule of financial information by reporting segment

	Year Ended December 31,
	2015		2014		2013
	(in thousands)
Net revenues:
Finished pharmaceutical products	$	224,941	$	198,480	$	229,681
API		26,578		11,981		—
Total net revenues		251,519		210,461		229,681
Gross Profit:
Finished pharmaceutical products		74,146		52,724		86,956
API		3,201		(1,468)		—
Total gross profit		77,347		51,256		86,956
Operating expenses		84,245		69,239		69,466
Income (loss) from operations		(6,898)		(17,983)		17,490
Non-operating income (expenses)		(3,466)		(165)		(263)
Income (loss) before income taxes	$	(10,364)	$	(18,148)	$	17,227

Schedule of net revenues and long-lived assets by geographic region

	Net Revenue						Long-Lived Assets
	Year Ended December 31,						December 31,
	2015		2014		2013		2015		2014
	(in thousands)
U.S.	$	243,295	$	198,480	$	229,681	$	100,404	$	102,313
China		—		—		—		28,547		22,170
France		8,224		11,981		—		13,210		13,806
Total	$	251,519	$	210,461	$	229,681	$	142,161	$	138,289